Tau Protein and β-Amyloid in Neurodegeneration Related to Multiple Sclerosis
Author Information
Author(s): Grażyna Pyka-Fościak, Ewa Jasek-Gajda, Bożena Wójcik, Grzegorz J. Lis, Jan A. Litwin
Primary Institution: Jagiellonian University Medical College
Hypothesis
An increase in β-APP levels is hypothesized to trigger tau pathology and subsequent neuronal death in multiple sclerosis.
Conclusion
The study found that the expression of p-tau increased with the progression of EAE, indicating its potential role in neurodegenerative mechanisms in multiple sclerosis.
Supporting Evidence
- β-APP expression increased during the peak phase of EAE and remained stable in the chronic phase.
- Tau protein was predominantly found in nerve fibers during the onset and peak phases but shifted to nerve cell perikaryons in the chronic phase.
- P-tau immunostaining was observed only in nerve fibers, with levels increasing in the chronic phase.
- Positive correlations were found between p-tau and axonal loss, and between β-APP and demyelination.
Takeaway
This study looked at how certain proteins related to Alzheimer's disease affect nerve damage in mice with a disease similar to multiple sclerosis.
Methodology
EAE was induced in C57BL/6 mice, and the expression of β-APP, tau, and p-tau was examined through immunohistochemistry in spinal cord sections.
Limitations
The study was conducted in a mouse model, which may not fully replicate human disease.
Participant Demographics
Female C57BL/6 mice, aged 10-11 weeks.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website